Blog Posts
Explore timely perspectives from WCG’s clinical trial operations and scientific leaders.
Cell & Gene Therapy
Key Takeaways From FDA’s New Draft Guidance, “Studying Multiple Versions of a Cellular or Gene Therapy Product in an Early-Phase Clinical Trial”
Blog Posts
Participant Recruitment
Does the IRB need to approve doctor-to-doctor letters?
Blog Posts
Regulatory Compliance
What are the IRB review requirements for human factors/usability testing?
Blog Posts
Five Tips for Improving Your Site’s Study Start-Up Timelines
Blog Posts
Clinical Endpoints
Choosing Between Provisioned, BYOD, and Hybrid Models for ePRO: Which Is Right for Your Clinical Trial?
Blog Posts
Clinical Endpoints
A Successful DMC Requires a Productive, Early Organizational Meeting
Blog Posts
Clinical Endpoints
CNS Trial Failure Rates High As Need for New Drugs Grows
Blog Posts
Clinical Endpoints
Can Your ePRO for Pediatric Clinical Trials Support Multiple Informants?
Blog Posts
Five Tips for Creating & Negotiating the Best Clinical Trial Budget for Your Site
Blog Posts
Clinical Trial Operations